Investor Information
TRL 5, Our IP Estate, For Investors, Join Us
Technology Maturity Assessment:
Validated at TRL 5
Technology Readiness Level
(TRL) 5
Our IP Estate
For Investors:
Scalable Impact + Multiple Exit Paths
Concept visualization. Device not yet FDA-approved.
Join Us
Our Purpose: Save Lives
Our Secret-Sauce: IP that Delivers on the Promise of Non-invasive Diagnostics
For Investors: Optionality & Flexibility: Multiple Markets, Applications, and Exits